Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000041

Director sold 1,666 shares at $18.42 ($30,688)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

SATO VICKI L · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-01-16 Sale : show line 1 in the form 10b5-1 −1,666 $18.42 $30,688 123,041 D
Open-market sales · 1,666 sh · avg $18.42 · $30,688
Loading xslF345X05/wk-form4_1705620357.xml…